BR9607427A - Inibiçao de angiogêne usando interleucina 12 - Google Patents

Inibiçao de angiogêne usando interleucina 12

Info

Publication number
BR9607427A
BR9607427A BR9607427A BR9607427A BR9607427A BR 9607427 A BR9607427 A BR 9607427A BR 9607427 A BR9607427 A BR 9607427A BR 9607427 A BR9607427 A BR 9607427A BR 9607427 A BR9607427 A BR 9607427A
Authority
BR
Brazil
Prior art keywords
angiogenes
interleukin
inhibition
Prior art date
Application number
BR9607427A
Other languages
English (en)
Portuguese (pt)
Inventor
Emile Eigene Voest
Gary Arthur Truitt
Moses Judah Folkman
Original Assignee
Hoffmann La Roche
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Childrens Medical Center filed Critical Hoffmann La Roche
Publication of BR9607427A publication Critical patent/BR9607427A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9607427A 1995-02-16 1996-02-07 Inibiçao de angiogêne usando interleucina 12 BR9607427A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38938295A 1995-02-16 1995-02-16
PCT/EP1996/000507 WO1996025171A1 (en) 1995-02-16 1996-02-07 Inhibition of angiogenesis using interleukin-12

Publications (1)

Publication Number Publication Date
BR9607427A true BR9607427A (pt) 1998-06-23

Family

ID=23538033

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9607427A BR9607427A (pt) 1995-02-16 1996-02-07 Inibiçao de angiogêne usando interleucina 12

Country Status (8)

Country Link
EP (1) EP0809511A1 (xx)
JP (1) JPH11500119A (xx)
AU (1) AU4788396A (xx)
BR (1) BR9607427A (xx)
CA (1) CA2212370A1 (xx)
FI (1) FI973356A (xx)
TR (1) TR199700801T1 (xx)
WO (1) WO1996025171A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2243161A1 (en) * 1996-11-22 1998-05-28 Toray Industries, Inc. Use of interferon-beta to treat retinal edema
US5981508A (en) 1997-01-29 1999-11-09 Vanderbilt University Facilitation of repair of neural injury with CM101/GBS toxin
US6670337B1 (en) 1998-01-29 2003-12-30 Yeda Reaearch And Development Co., Ltd. Facilitation of wound healing with CM101/GBS toxin
US6028060A (en) 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US5858991A (en) * 1997-01-29 1999-01-12 Vanderbilt University Facilitation of wound healing with CM101/GBS toxin
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
EP0986393B1 (en) * 1997-05-27 2004-03-24 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
CA2308438A1 (en) * 1997-11-03 1999-05-14 The Wistar Institute Of Anatomy And Biology Method and compositions for inhibiting angiogenesis and treating cancer
WO2002079157A1 (en) 2001-03-29 2002-10-10 Schering Corporation Aryl oxime-piperazines useful as ccr5 antagonists
AU2003292838A1 (en) * 2002-12-27 2004-07-29 Kirin Beer Kabushiki Kaisha Therapeutic agent for wet age-related macular degeneration
AU2004224191A1 (en) 2003-03-24 2004-10-07 F. Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors
KR20080056220A (ko) 2005-10-19 2008-06-20 에프. 호프만-라 로슈 아게 페닐-아세트아마이드 ｎｎｒｔ 저해제
PT2057125E (pt) 2006-08-16 2011-05-31 Hoffmann La Roche Inibidores n?o nucle?sidos de transcriptase inversa
ES2550152T3 (es) 2006-12-13 2015-11-04 F. Hoffmann-La Roche Ag Derivados de 2-(piperidin-4-il)-4-fenoxi-o fenilamino-pirimidina como inhibidores no nucleósidos de transcriptasa inversa
KR20190039145A (ko) * 2016-07-18 2019-04-10 뉴메디슨즈, 인코포레이티드 대체 면역요법으로서의 il-12의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013794A1 (en) * 1992-01-16 1993-07-22 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
JPH06157344A (ja) * 1992-02-07 1994-06-03 Childrens Medical Center Corp:The 血管新生阻害のための医薬製剤及び血管新生阻害方法

Also Published As

Publication number Publication date
JPH11500119A (ja) 1999-01-06
MX9706188A (es) 1997-11-29
TR199700801T1 (xx) 1998-03-21
EP0809511A1 (en) 1997-12-03
AU4788396A (en) 1996-09-04
FI973356A0 (fi) 1997-08-15
FI973356A (fi) 1997-08-15
WO1996025171A1 (en) 1996-08-22
CA2212370A1 (en) 1996-08-22

Similar Documents

Publication Publication Date Title
BR9609772A (pt) Redução de bioincrustações
DE59605821D1 (de) l/4-SCALLABSORBER
BR9609797A (pt) Inibição de expressão de gene
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
BR9609726A (pt) Inibição de expressão de gene
BR9611475A (pt) 5-aminoisotiaz is acilados
BR9607427A (pt) Inibiçao de angiogêne usando interleucina 12
PT874854E (pt) Antibioticos de cefalosporina
IT1276799B1 (it) Formulazioni di f-silicone
FR2731885B1 (fr) Installation d'etageres demontables
NO961404D0 (no) 4-indolylpiperazinyl-derivater
GB9621852D0 (en) Inhibition of scale
NO960353D0 (no) 4-aminobenzoylguanidinderivater
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
NO960392D0 (no) 4-merkaptobenzoylguanidinderivater
FI953319A0 (fi) Dimetyylinaftaleenin valmistus
FR2735986B3 (fr) Prolongateur d'haltere
PT761766E (pt) Compostos assimetricos de trifenilenodioxazina
UA1112S (uk) Мікро-еом широкого призначення
KR970011853U (ko) 새로운 형태의 메리야스
KR970027978U (ko) 슬라이드 햄머의 구조
ITMI951551A0 (it) Composizioni orosolubili di n-acetilcisteina
ITTV950114A0 (it) Struttura di tavolino-sgabello
KR960031416U (ko) 투포원연사기의 스핀들
KR970041939U (ko) 부품의 방진체결구조

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law